TY - JOUR
T1 - Plasma Ammonia Levels in Preterm Infants Receiving Parenteral Nutrition with Crystalline L-Amino Acids
AU - Shohat, M.
AU - Wielunsky, E.
AU - Reisner, S. H.
PY - 1984/3
Y1 - 1984/3
N2 - In order to investigate the severity and incidence of hyperammonemia in preterm infants receiving total parenteral nutrition (TPN) with crystalline L-amino acids having high arginine content (Travasol), we determined the plasma ammonia (PA) levels in a group of 29 preterm infants on TPN, weekly and 1 wk posttherapy. Their mean gestational age was 29.9 ± 2.6 wk and mean birth weight 1208 ± 262 g. Thirty five blood samples obtained from 15 preterm infants not on TPN with mean gestational age 32.2 ± 1.9 wk and a birth weight of 1495 ± 161 g served as a control. In the parenteral nutrition group the mean PA level (140 ± 58 μg/100 ml) was significantly higher (p < 0.001) than that in the same group one week post TPN (97 ± 34 μg/100 ml) and in the control group (86 ± 35 μg/100 ml). The incidence of hyperammonemia (>160 μg/100 ml) was 30% in the TPN group versus 3% in the controls (p < 0.01). Maximal PA level during that treatment was 405 versus 216 μg/100 ml 1 wk post-TPN versus 163 μg/100 ml in the controls. The data show a significant increase in PA levels in preterm infants receiving TPN with Travasol, possibly because of its high glycine content. (Journal of Parenteral and Enteral Nutrition 8:178-180, 1984).
AB - In order to investigate the severity and incidence of hyperammonemia in preterm infants receiving total parenteral nutrition (TPN) with crystalline L-amino acids having high arginine content (Travasol), we determined the plasma ammonia (PA) levels in a group of 29 preterm infants on TPN, weekly and 1 wk posttherapy. Their mean gestational age was 29.9 ± 2.6 wk and mean birth weight 1208 ± 262 g. Thirty five blood samples obtained from 15 preterm infants not on TPN with mean gestational age 32.2 ± 1.9 wk and a birth weight of 1495 ± 161 g served as a control. In the parenteral nutrition group the mean PA level (140 ± 58 μg/100 ml) was significantly higher (p < 0.001) than that in the same group one week post TPN (97 ± 34 μg/100 ml) and in the control group (86 ± 35 μg/100 ml). The incidence of hyperammonemia (>160 μg/100 ml) was 30% in the TPN group versus 3% in the controls (p < 0.01). Maximal PA level during that treatment was 405 versus 216 μg/100 ml 1 wk post-TPN versus 163 μg/100 ml in the controls. The data show a significant increase in PA levels in preterm infants receiving TPN with Travasol, possibly because of its high glycine content. (Journal of Parenteral and Enteral Nutrition 8:178-180, 1984).
UR - http://www.scopus.com/inward/record.url?scp=0021329743&partnerID=8YFLogxK
U2 - 10.1177/0148607184008002178
DO - 10.1177/0148607184008002178
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0021329743
SN - 0148-6071
VL - 8
SP - 178
EP - 180
JO - Journal of Parenteral and Enteral Nutrition
JF - Journal of Parenteral and Enteral Nutrition
IS - 2
ER -